GPI S.p.A. operates in the field of social-healthcare IT services and hi-tech services for healthcare markets in Italy and internationally. The company offers software solutions for population health management, health administration, hospital information, social and continuum care information systems, diagnostics, blood and laboratory information systems, care services and technologies, drug logistics, public administration, cyber security and IT services, artificial intelligence, interoperability, business intelligence and data analytics, and wearables and IoT, as well as tissue bank and human resources. It also provides advisory and design capabilities that enables it to operate in a range of business areas, including automation and ICT services; and develops a modular suite of software products that support the diagnostic, clinical, and reception activities of public and private health care facilities, and territorial medicine networks. In addition, the company offers Phasys System, a hardware and software solution for medication management in healthcare structures; RIEDL Phasys System for the automation of drug distribution in pharmacies; ICT services; public administration payment solutions; and retail and banking sector payment solutions. Further, it provides desktop services, such as design, implementation, and maintenance of technological infrastructure; consultancy and IT assistance; supply of solutions for public administration; help desk services and facility management for local and central PA, healthcare providers, multi-utilities, and private companies; trouble ticketing system; and design of integrated systems. GPI S.p.A. was founded in 1988 and is headquartered in Trento, Italy. GPI S.p.A. operates as a subsidiary of FM S.r.l.
Metrics to compare | GPI | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipGPIPeersSector | |
---|---|---|---|---|
P/E Ratio | 36.5x | 14.1x | −0.7x | |
PEG Ratio | 0.03 | −0.16 | 0.00 | |
Price/Book | 1.1x | 2.7x | 2.6x | |
Price / LTM Sales | 0.7x | 2.4x | 3.2x | |
Upside (Analyst Target) | 41.3% | 30.5% | 47.0% | |
Fair Value Upside | Unlock | 6.9% | 7.5% | Unlock |